Patents by Inventor Robert E. Atkinson
Robert E. Atkinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190090890Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.Type: ApplicationFiled: November 27, 2018Publication date: March 28, 2019Applicant: BRIDGEPOINT MEDICAL, INC.Inventors: CHAD J. KUGLER, MATTHEW J. OLSON, ROBERT E. ATKINSON
-
Publication number: 20190059927Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.Type: ApplicationFiled: October 30, 2018Publication date: February 28, 2019Applicant: Bridgepoint Medical, Inc.Inventors: Chad J. Kugler, Robert E. Atkinson
-
Patent number: 10166035Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.Type: GrantFiled: March 7, 2016Date of Patent: January 1, 2019Assignee: BRIDGEPOINT MEDICAL, INC.Inventors: Chad J. Kugler, Matthew J. Olson, Robert E. Atkinson
-
Patent number: 10143487Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.Type: GrantFiled: December 10, 2015Date of Patent: December 4, 2018Assignee: Bridgepoint Medical, Inc.Inventors: Chad J. Kugler, Robert E. Atkinson
-
Patent number: 10105538Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.Type: GrantFiled: December 29, 2010Date of Patent: October 23, 2018Assignee: Cyberonics, Inc.Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson
-
Publication number: 20180200512Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea. The system is adapted to send an electrical signal from an implanted neurostimulator through a stimulation lead to a patient's nerve at an appropriate phase of the respiratory cycle based on input from a respiration sensing lead. External components are adapted for wireless communication with the neurostimulator. The neurostimulator is adapted to deliver therapeutic stimulation based on inputs.Type: ApplicationFiled: March 12, 2018Publication date: July 19, 2018Applicant: Cyberonics, Inc.Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Wondimeneh Tesfayesus, Jason J. Skubitz, Mark R. Bosshard, Daniel A. Parrish, Robert E. Atkinson
-
Publication number: 20180078761Abstract: A method including chronically implanting a nerve cuff electrode on a portion of a hypoglossal nerve, chronically implanting a respiration sensing lead subcutaneously in a thorax of a patient, the respiration sensing lead having a plurality of bio-impedance electrodes defining at least one bio-impedance vector. The method may also include sensing a bio-impedance signal corresponding to respiration via a bio-impedance vector on an anterior side of the thorax, analyzing the bio-impedance signal to identify onsets of expiration, predicting an onset of a future expiratory phase, and delivering a stimulus to the portion of the hypoglossal nerve via the nerve cuff electrode, wherein the stimulus is delivered as a function of the bio-impedance signal; wherein stimulus delivery is initiated before the onset of the future expiratory phase and continued during an entire inspiratory phase, and wherein the method is performed without identifying an onset of an inspiratory phase.Type: ApplicationFiled: July 31, 2017Publication date: March 22, 2018Applicant: CYBERONICS, Inc.Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
-
Patent number: 9913982Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea. The system is adapted to send an electrical signal from an implanted neurostimulator through a stimulation lead to a patient's nerve at an appropriate phase of the respiratory cycle based on input from a respiration sensing lead. External components are adapted for wireless communication with the neurostimulator. The neurostimulator is adapted to deliver therapeutic stimulation based on inputs.Type: GrantFiled: May 12, 2011Date of Patent: March 13, 2018Assignee: Cyberonics, Inc.Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Wondimeneh Tesfayesus, Jason J. Skubitz, Mark R. Bosshard, Daniel A. Parrish, Robert E. Atkinson
-
Patent number: 9877825Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.Type: GrantFiled: June 8, 2016Date of Patent: January 30, 2018Assignees: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. Kahook, Naresh Mandava, Paul McLean, Robert E. Atkinson
-
Publication number: 20180014928Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.Type: ApplicationFiled: May 10, 2017Publication date: January 18, 2018Applicants: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. KAHOOK, Naresh MANDAVA, Glenn SUSSMAN, Paul McLEAN, Robert E. ATKINSON
-
Publication number: 20180008824Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.Type: ApplicationFiled: August 25, 2017Publication date: January 11, 2018Applicant: Cyberonics, Inc.Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson, Peter R. Eastwood, David R. Hillman
-
Publication number: 20180000513Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes inserting an intramural crossing device into the vascular lumen, positioning at least the distal tip of the crossing device in the vascular wall, advancing an orienting device over the crossing device such that an orienting element of the orienting device resides in the vascular wall, inserting a reentry device, and re-entering the true vascular lumen.Type: ApplicationFiled: September 14, 2017Publication date: January 4, 2018Applicant: BridgePoint Medical, Inc.Inventors: CHAD J. KUGLER, ROBERT E. ATKINSON, MATTHEW J. OLSON
-
Publication number: 20170319332Abstract: Intraocular lenses (IOLs) that improve lens stability by, for example, increasing anterior-posterior stiffness of the IOL, increasing anterior-posterior dimensions of the IOL and/or increasing contact area with the equator of the bag to resist movement of the IOL as the bag collapses over time. These IOLs may be non-modular (single component) or modular (multiple component). In modular embodiments, the IOL system may include intraocular base and optic components, which, when combined, form a modular IOL.Type: ApplicationFiled: May 3, 2017Publication date: November 9, 2017Applicants: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. KAHOOK, Glenn SUSSMAN, Rudolph F. ZACHER, Paul J. McLEAN, Robert E. ATKINSON
-
Patent number: 9788855Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes inserting an intramural crossing device into the vascular lumen, positioning at least the distal tip of the crossing device in the vascular wall, advancing an orienting device over the crossing device such that an orienting element of the orienting device resides in the vascular wall, inserting a reentry device, and re-entering the true vascular lumen.Type: GrantFiled: November 25, 2014Date of Patent: October 17, 2017Assignee: BridgePoint Medical, Inc.Inventors: Chad J. Kugler, Robert E. Atkinson, Matthew J. Olson
-
Patent number: 9744354Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.Type: GrantFiled: December 30, 2009Date of Patent: August 29, 2017Assignee: CYBERONICS, INC.Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson, Peter R. Eastwood, David R. Hillman
-
Patent number: 9681946Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.Type: GrantFiled: February 26, 2016Date of Patent: June 20, 2017Assignees: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. Kahook, Naresh Mandava, Glenn Sussman, Paul McLean, Robert E. Atkinson
-
Publication number: 20160375232Abstract: Devices and methods for less invasively treating the gastrointestinal system, such as the intestinal mucosa of the small bowel. Embodiments described herein may be used to reduce caloric absorption and effectuate weight loss, for example.Type: ApplicationFiled: September 9, 2016Publication date: December 29, 2016Inventors: Chad J. KUGLER, Robert E. ATKINSON
-
Publication number: 20160278912Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.Type: ApplicationFiled: June 8, 2016Publication date: September 29, 2016Applicants: The Regents of the University of Colorado, a body corporate, ClarVista Medical, Inc.Inventors: Malik Y. KAHOOK, Naresh MANDAVA, Paul MCLEAN, Robert E. ATKINSON
-
Publication number: 20160235587Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.Type: ApplicationFiled: February 26, 2016Publication date: August 18, 2016Applicants: ClarVista Medical, Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. KAHOOK, Naresh MANDAVA, Glenn SUSSMAN, Paul McLEAN, Robert E. ATKINSON
-
Patent number: 9387069Abstract: A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary lens for stability. Such attachment may reside radially inside the perimeter of the capsulorhexis and radially outside the field of view to avoid interference with light transmission.Type: GrantFiled: July 24, 2015Date of Patent: July 12, 2016Assignees: ClarViata Medical, Inc., The Regents of the University of Colorado, a body corporateInventors: Malik Y. Kahook, Naresh Mandava, Paul McLean, Robert E. Atkinson